Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease.
Cardiovasc Drugs Ther
; 2023 Jan 07.
Article
in En
| MEDLINE
| ID: mdl-36609948
Full text:
1
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
Cardiovasc Drugs Ther
Journal subject:
ANGIOLOGIA
/
CARDIOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2023
Type:
Article
Affiliation country:
Taiwan